Synchroz Pharmaceuticals Private Limited
About Synchroz Pharmaceuticals Private Limited
Data last updated:
Synchroz Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 06 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2013PTC092907. Its GSTIN is 33AATCS6837P1ZC (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mutham Perumal Sumathi Nadarajan and Ashokan Murugan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.215 Krishna Nagar Main Road Nerkundram, Chennai, Tamil Nadu, India – 600107.
As per the financials filed for FY 2024, the company reported a revenue of ₹72.62 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.3 Lakh (net margin 1.8%) and EBITDA of ₹1.97 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.215 Krishna Nagar Main Road Nerkundram, Chennai, Tamil Nadu, India – 600107
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Synchroz Pharmaceuticals Private Limited
The main business activity of Synchroz Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Synchroz Pharmaceuticals Private Limited FY 2025 filings available
Synchroz Pharmaceuticals Private Limited reported revenue of ₹72.62 Lakh (down 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Synchroz Pharmaceuticals Private Limited
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Synchroz Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.97 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.3 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Synchroz Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synchroz Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Synchroz Pharmaceuticals Private Limited
Synchroz Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abia Pharmaceuticals Private Limited | ₹73.13 Lakh (FY 2024) | •••• | •••• | -70.0% | •••• | Chennai, Tamil Nadu, India |
| Tirupati Pharmaceuticals Private Limited | ₹73.07 Lakh (FY 2021) | •••• | •••• | -30.0% | •••• | New Delhi, Delhi, India |
| Addicott Pharmaceuticals Private Limited | ₹73.05 Lakh (FY 2024) | •••• | •••• | 112.0% | •••• | Madhepura, Bihar, India |
| Digilent Pharmaceuticals Private Limited | ₹72.79 Lakh (FY 2025) | •••• | •••• | 43.0% | •••• | Mumbai, Maharashtra, India |
| San-Pen Pharmaceuticals Private Limited | ₹72.76 Lakh (FY 2025) | •••• | •••• | 189.0% | •••• | Mumbai, Maharashtra, India |
| Synchroz Pharmaceuticals Private Limited this company | ₹72.62 Lakh (FY 2024) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| Milkyway Pharmaceuticals Private Limited | ₹72.57 Lakh (FY 2025) | •••• | •••• | 161.0% | •••• | Mandya, Karnataka, India |
| Ambush Pharmaceuticals Private Limited | ₹72.21 Lakh (FY 2016) | •••• | •••• | 93.0% | •••• | Karnal, Haryana, India |
| MHS Pharmaceuticals Private Limited | ₹72.2 Lakh (FY 2024) | •••• | •••• | -27.0% | •••• | Hyderabad, Telangana, India |
| Voluenta Pharmaceuticals Private Limited | ₹72.03 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | New Delhi, Delhi, India |
| Krishbaj India Pharmaceuticals Private Limited | ₹71.86 Lakh (FY 2024) | •••• | •••• | -24.0% | •••• | Bhubaneswar, Odisha, India |
Peers are the five companies nearest above and the five nearest below Synchroz Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Synchroz Pharmaceuticals Private Limited
Synchroz Pharmaceuticals Private Limited is audited by 5/30, Jasmina, 2nd Floor, Co-operative Colony for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| 5/30, Jasmina, 2nd Floor, Co-operative Colony | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Synchroz Pharmaceuticals Private Limited
Synchroz Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mutham Perumal Sumathi Nadarajan | Director | 06 Sep 2013 | 13 Years 1 Months | Current |
| Ashokan Murugan | Director | 06 Sep 2013 | 13 Years 1 Months | Current |
Ownership and Shareholding of Synchroz Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Synchroz Pharmaceuticals Private Limited
Synchroz Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Synchroz Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Synchroz Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Synchroz Pharmaceuticals Private Limited
Synchroz Pharmaceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Ashokan Murugan was appointed as Director on 06 Sep 2013.
Credit Ratings, Litigation & Regulatory Alerts for Synchroz Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Synchroz Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Synchroz Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Synchroz Pharmaceuticals Private Limited
Synchroz Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AATCS6837P1ZC | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Synchroz Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synchroz Pharmaceuticals Private Limited
Synchroz Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in chemical products, within the chemicals industry. It was incorporated on 06 September 2013 (13+ years old) and is registered under CIN U24232TN2013PTC092907.
Synchroz Pharmaceuticals reported revenue of ₹72.62 Lakh for FY 2024 (down 5% YoY).
Synchroz Pharmaceuticals has 2 current directors:
- Mutham Perumal Sumathi Nadarajan - Director
- Ashokan Murugan - Director
Synchroz Pharmaceuticals reported a net profit of ₹1.3 Lakh (net margin 1.8%) and EBITDA of ₹1.97 Lakh (EBITDA margin 2.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Synchroz Pharmaceuticals is 3% over three years and 7% over five years. In the latest year (FY 2024) revenue fell 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Synchroz Pharmaceuticals is 33AATCS6837P1ZC, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Synchroz Pharmaceuticals is U24232TN2013PTC092907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synchroz Pharmaceuticals was incorporated on 06 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Synchroz Pharmaceuticals by revenue are Abia Pharmaceuticals Private Limited, Tirupati Pharmaceuticals Private Limited, Addicott Pharmaceuticals Private Limited, Digilent Pharmaceuticals Private Limited, San-Pen Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ashokan Murugan was appointed as Director on 06 Sep 2013. Mutham Perumal Sumathi Nadarajan was appointed as Director on 06 Sep 2013.
The registered office of Synchroz Pharmaceuticals is at No.215 Krishna Nagar Main Road Nerkundram, Chennai, Tamil Nadu, India – 600107.